| First Author | Liu YL | Year | 2016 |
| Journal | Blood | Volume | 127 |
| Issue | 15 | Pages | 1912-22 |
| PubMed ID | 26764354 | Mgi Jnum | J:232645 |
| Mgi Id | MGI:5779753 | Doi | 10.1182/blood-2015-05-646216 |
| Citation | Liu YL, et al. (2016) Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy. Blood 127(15):1912-22 |
| abstractText | Juvenile myelomonocytic leukemia (JMML) is an aggressive pediatric mixed myelodysplastic/myeloproliferative neoplasm (MDS/MPN). JMML leukemogenesis is linked to a hyperactivated RAS pathway, with driver mutations in theKRAS,NRAS,NF1,PTPN11, orCBLgenes. Previous murine models demonstrated how those genes contributed to the selective hypersensitivity of JMML cells to granulocyte macrophage-colony-stimulating factor (GM-CSF), a unifying characteristic in the disease. However, it is unclear what causes the early death in children with JMML, because transformation to acute leukemia is rare. Here, we demonstrate that loss of Pten (phosphatase and tensin homolog) protein at postnatal day 8 in mice harboringNf1haploinsufficiency results in an aggressive MPN with death at a murine prepubertal age of 20 to 35 days (equivalent to an early juvenile age in JMML patients). The death in the mice was due to organ infiltration with monocytes/macrophages. There were elevated activities of protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) in cells at physiological concentrations of GM-CSF. These were more pronounced in mice withNf1haploinsufficiency than in littermates with wild-typeNf1,but this model is insufficient to cause cells to be GM-CSF hypersensitive. This new model represents a murine MPN model with features of a pediatric unclassifiable mixed MDS/MPN and mimics many clinical manifestations of JMML in terms of age of onset, aggressiveness, and organ infiltration with monocytes/macrophages. Our data suggest that the timing of the loss of PTEN protein plays a critical role in determining the disease severity in myeloid malignancies. This model may be useful for studying the pathogenesis of pediatric diseases with alterations in the Ras pathway. |
